![]() |
市場調查報告書
商品編碼
1971514
導管市場-全球產業規模、佔有率、趨勢、機會和預測:按產品類型、最終用途、地區和競爭格局分類,2021-2031年Catheter Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By End Use (Hospital Stores, Retail Stores, Others), By Region & Competition, 2021-2031F |
||||||
全球導管市場預計將從 2025 年的 590.2 億美元成長到 2031 年的 837.7 億美元,複合年成長率為 6.01%。
導管是一種細長的醫用管,用於在外科手術或治療性介入中,從體腔、管腔或血管中註入、輸送或排放體液。推動這一市場發展的主要動力是慢性疾病(例如泌尿系統疾病和心血管疾病)的盛行率上升,這些疾病需要微創治療。此外,全球人口老化也導致需要使用這些器械進行有效患者照護的外科手術數量增加。正如美國心臟協會在2024年報告的那樣,心血管疾病約佔全球所有死亡人數的三分之一,凸顯了對心臟介入器材的持續需求。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 590.2億美元 |
| 市場規模:2031年 | 837.7億美元 |
| 複合年成長率:2026-2031年 | 6.01% |
| 成長最快的細分市場 | 向醫院銷售 |
| 最大的市場 | 北美洲 |
然而,醫療相關感染率居高不下,尤其是與泌尿道器械相關的感染,是市場成長的主要障礙。這些併發症往往導致住院時間延長和醫療成本增加,迫使醫療機構實施嚴格的通訊協定。因此,一些醫療機構為了降低風險,限制了這些器材的常規或長期使用,這阻礙了整體市場成長。
微創診斷和手術技術的日益普及是全球導管市場的主要驅動力。醫療機構越來越重視能夠減輕患者身體負擔和縮短復健時間的治療方法,這種轉變正在加速專業介入工具的研發和應用,尤其是在結構性心臟病治療和心臟電生理領域。對這些先進系統的需求也反映在主要產業參與者的財務表現中。例如,波士頓科學公司在2024年10月報告稱,其電生理業務(主要得益於FARAPULSE脈衝電場消融系統)的全球淨銷售額同比成長177.0%。同樣,雅培醫療設備部門在2024年第三季的銷售額成長了11.7%,達到47.5億美元,這主要得益於導管密集型領域的兩位數成長。
同時,將人工智慧和智慧感測器整合到導管設計中,正透過提升病患安全性和臨床決策能力,改變市場格局。製造商們正超越被動式導管,致力於生產能夠提供預測分析和即時血流動力學數據的智慧系統,這些數據對於重症監護環境至關重要。這一趨勢正在推動市場整合和對先進監測技術的投資。 2024年9月,貝克頓·迪金森公司(BD)以42億美元完成了對愛德華生命科學公司重症監護部門的收購,進一步拓展了其人工智慧驅動的臨床決策支援工具和智慧互聯護理解決方案的產品組合。這正是產業轉型為高科技、感測器整合設備的例子。
醫療相關感染(HAI)的普遍發生,尤其是導尿管相關尿道感染(CAUTI),是全球導尿管市場發展的主要限制因素。這個問題迫使醫療機構實施嚴格的「避免使用導尿管」策略,以控制成本並最大限度地降低患者風險,從而阻礙了市場成長。醫院常因院內感染而面臨經濟處罰和保險拒保,導致醫療機構採取限制常規留置導尿管插入或強制早期拔除的通訊協定。這種運作模式的轉變導致導尿管的使用量和更換量顯著下降,進而降低了市場對這些耗材的整體需求。
根除這些感染疾病的難度進一步加劇了採取限制性措施的必要性,並限制了可觸及的市場規模。根據歐洲疾病預防控制中心 (ECDC) 2024 年的數據,尿道感染佔急性護理醫院報告的醫療相關感染疾病總數的 19.2%。這項統計數據表明,儘管醫學取得了進步,但使用泌尿裝置仍然是感染疾病併發症的主要原因。因此,為降低感染發生率而持續進行的工作迫使醫療系統優先考慮替代治療方法而非導尿管插入,這直接阻礙了以銷售主導的市場成長。
居家醫療的日益普及正在加速親水性拋棄式間歇性導尿管的推廣應用。患者越來越傾向於選擇摩擦力小、適合自我導尿的裝置,因為與長期留置導尿管相比,此類裝置可降低尿道損傷和併發症的風險。這種對自主性和舒適性的重視正在推動泌尿系統領域的銷售成長,而該領域尤其注重使用者體驗。例如,科樂普公司在2024年8月的中期財務報告中指出,其失禁護理業務年初至今實現了8%的內部成長,這主要得益於Luja系列間歇導尿管的成功上市和廣泛應用。
同時,具備血管內碎石功能的下一代球囊導管的進步正在革新複雜鈣化心血管病變的治療。這些先進設備利用聲波壓力擊碎動脈壁內的鈣質,為傳統的高壓球囊提供了更安全的替代方案,後者有血管撕裂的風險。鑑於這項技術在冠狀動脈和周邊動脈疾病治療中具有極高的臨床價值,主要企業正大力投資以獲取這些平台。特別是強生公司,於2024年5月完成了對Shockwave Medical的收購,交易金額約為131億美元,旨在將其在醫療技術領域的領先地位擴展到血管鈣化治療和心臟功能恢復領域。
The Global Catheter Market is projected to expand from USD 59.02 Billion in 2025 to USD 83.77 Billion by 2031, reflecting a CAGR of 6.01%. Catheters are thin medical tubes utilized to inject, administer, or drain fluids from body cavities, ducts, or vessels during surgical and therapeutic interventions. Key drivers propelling this market include the rising prevalence of chronic conditions, such as urinary disorders and cardiovascular diseases, which demand minimally invasive treatments. Additionally, the aging global population is increasing the volume of surgical procedures that require these devices for effective patient care. As reported by the American Heart Association in 2024, cardiovascular disease was responsible for approximately one in three deaths worldwide, underscoring the sustained need for cardiac interventional tools.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 59.02 Billion |
| Market Size 2031 | USD 83.77 Billion |
| CAGR 2026-2031 | 6.01% |
| Fastest Growing Segment | Hospital Stores |
| Largest Market | North America |
However, market growth faces a significant hurdle due to the high rate of healthcare-associated infections, particularly those linked to urinary tract instrumentation. These complications frequently lead to extended hospitalizations and increased medical costs, compelling healthcare providers to enforce strict protocols. As a result, institutions may limit the routine or prolonged use of these devices to minimize risks, which subsequently restricts the overall utilization and expansion of the market.
Market Driver
The growing preference for minimally invasive diagnostic and surgical techniques is a primary force driving the global catheter market, as healthcare providers increasingly favor methods that decrease patient trauma and recovery times. This shift has accelerated the development and consumption of specialized interventional tools, especially within structural heart therapies and cardiac electrophysiology. The demand for these advanced systems is reflected in the financial results of major industry players; for instance, Boston Scientific reported in October 2024 that its Electrophysiology business, driven by the FARAPULSE Pulsed Field Ablation system, saw a global net sales increase of 177.0% compared to the previous year. Similarly, Abbott's Medical Devices segment recorded an 11.7% sales increase to $4.75 billion in the third quarter of 2024, supported by double-digit growth in catheter-intensive sectors.
concurrently, the integration of artificial intelligence and smart sensors into catheter designs is transforming the market by improving patient safety and clinical decision-making. Manufacturers are evolving beyond passive tubing to produce intelligent systems capable of delivering predictive analytics and real-time hemodynamic data, which are vital in critical care settings. This trend has triggered significant market consolidation and investment in advanced monitoring technologies. In September 2024, Becton, Dickinson and Company (BD) finalized the acquisition of Edwards Lifesciences' Critical Care unit for $4.2 billion to broaden its portfolio of AI-enabled clinical decision tools and smart connected care solutions, highlighting the industry's pivot toward high-tech, sensor-integrated devices.
Market Challenge
The widespread occurrence of healthcare-associated infections (HAIs), specifically catheter-associated urinary tract infections (CAUTIs), serves as a major restraint on the Global Catheter Market. This issue hampers growth by forcing healthcare facilities to implement rigorous "catheter-avoidance" strategies to control costs and minimize patient risk. Since hospitals often face financial penalties and non-reimbursement for hospital-acquired conditions, providers are adopting protocols that restrict the routine placement or mandate the early removal of indwelling catheters. This operational shift significantly lowers the frequency of device usage and the volume of replacements, thereby reducing the overall market demand for these consumables.
The persistence of these infections reinforces the need for such restrictive measures, limiting the addressable market size. Data from the European Centre for Disease Prevention and Control in 2024 indicates that urinary tract infections comprised 19.2% of all reported healthcare-associated infections in acute care hospitals. This statistic demonstrates that despite improvements in care, urinary instrumentation remains a leading cause of infectious complications. Consequently, the continued focus on reducing this rate compels healthcare systems to prioritize alternative management methods over catheterization, directly impeding the volume-driven growth of the market.
Market Trends
The rise of home-based patient care is accelerating the adoption of hydrophilic single-use intermittent catheters. Patients increasingly prefer these low-friction devices for self-catheterization because they lower the risk of urethral trauma and complications compared to long-term indwelling tubes. This shift toward independence and comfort is driving higher sales volumes for urology divisions focused on user experience. For example, Coloplast reported in its August 2024 interim financial report that its Continence Care business achieved 8% organic growth year-to-date, a performance largely attributed to the successful launch and adoption of the Luja intermittent catheter series.
Simultaneously, the advancement of next-generation balloon catheters equipped with intravascular lithotripsy is revolutionizing the treatment of complex calcified cardiovascular lesions. These sophisticated devices employ sonic pressure waves to fracture calcium within artery walls, providing a safer alternative to traditional high-pressure balloons that carry a risk of vessel dissection. Recognizing the high clinical value of this technology for treating coronary and peripheral artery disease, major corporations are investing heavily to secure these platforms. Notably, Johnson & Johnson completed the acquisition of Shockwave Medical in May 2024 for approximately $13.1 billion, aiming to extend its medtech leadership into vascular calcium modification and heart recovery.
Report Scope
In this report, the Global Catheter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Catheter Market.
Global Catheter Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: